Questions_and_Answer_75D301-18-R-67993.docx
DOCX document 14 KB Posted
- Attached to
- Adult Flu Vaccines 2019-2020
- Solicitation number
- 75D301-18-R-67993
About this file
This document contains questions and answers regarding solicitation number 75D301-18-R-67993 from the Centers for Disease Control and Prevention for adult influenza vaccines for the 2019-2020 season. The CDC requires contracts for the purchase of influenza vaccine for adults aged 19 years and older, with a minimum order size of 100 doses and a federal excise tax of $0.75 per dose. The maximum quantity is 6 million doses. Awards will be made by December 28, 2018, and pricing will be posted to the Federal Business Opportunities website after award. Bids may include products pending FDA approval by the award date. The proposal due date of October 9, 2018 cannot be extended.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 75D301-18-R-67993.doc | DOC document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Questions and Answers 75D301-18-R-67993
1. Would you be able to tell me when CDC anticipates making the award?
The contract(s) will be awarded by 12/28/18.
1. Can you also let me know when CDC anticipates posting the pricing on the website?
The awarded amounts will be posted on fbo.gov post contract(s) award
1. Can we bid a product that is pending approval? We have a product pending approval in December?
The vendor should not bid the product if it will not have FDA approval by contract award. If they think they can have FDA approval by contract award they can bid.
1. Can you extend the proposal due date?
The proposal due date cannot be extended and remains the same at 10/9/18.
File details come from the government source that posted it. Updated .